Topic: Joe Ladepo

Florida Surgeon General Joe Ladepo is seeking increased access to GlaxoSmithKline's monoclonal antibody treatment, Sotirivumab, which remains effective against the Omicron variant. Other treatments like Regeneron and Eli Lilly products have been set aside as they are less effective against new mutations. There are allegations that the federal government is blocking the distribution of these life-saving treatments to specific states.

Immunity to specific viral strains, such as those from the Spanish Flu, has been shown to last a lifetime. While natural immunity is robust, the Omicron variant's rapid replication allows it to bypass some existing defenses. In Florida, Surgeon General Joe Ladepo and Governor Ron DeSantis are actively fighting federal efforts to restrict access to monoclonal antibody treatments for their citizens.